Kaempferol acts as a potential therapeutic agent for the treatmentof DCM, as it can prevent diabetes-induced inflammation, oxidative stress,myocardial fibrosis, and apoptosis, mechanically linked to the inhibition ofNF-κB and Nrf-2 signaling pathway activation [59]. This evidence concerns the gene NFE2L2 and familial dilated cardiomyopathy.